Verdiana Ravarotto

654 total citations
29 papers, 477 citations indexed

About

Verdiana Ravarotto is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, Verdiana Ravarotto has authored 29 papers receiving a total of 477 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cardiology and Cardiovascular Medicine, 10 papers in Endocrinology, Diabetes and Metabolism and 10 papers in Physiology. Recurrent topics in Verdiana Ravarotto's work include Hormonal Regulation and Hypertension (9 papers), Renin-Angiotensin System Studies (8 papers) and Nitric Oxide and Endothelin Effects (5 papers). Verdiana Ravarotto is often cited by papers focused on Hormonal Regulation and Hypertension (9 papers), Renin-Angiotensin System Studies (8 papers) and Nitric Oxide and Endothelin Effects (5 papers). Verdiana Ravarotto collaborates with scholars based in Italy, United States and Switzerland. Verdiana Ravarotto's co-authors include Lorenzo A. Calò, Elisa Pagnin, Paul A. Davis, Teresa Maria Seccia, Giuseppe Maiolino, Gianni Carraro, Federico Nalesso, Gian Paolo Rossi, Laura Gobbi and M Lupia and has published in prestigious journals such as PLoS ONE, Nutrients and Life Sciences.

In The Last Decade

Verdiana Ravarotto

29 papers receiving 472 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Verdiana Ravarotto Italy 13 148 127 126 114 71 29 477
Gema Marín‐Royo Spain 8 176 1.2× 101 0.8× 100 0.8× 80 0.7× 132 1.9× 11 520
Nicolas Godin Canada 7 185 1.3× 81 0.6× 48 0.4× 122 1.1× 74 1.0× 8 437
Jinjuan Fu China 12 245 1.7× 101 0.8× 141 1.1× 37 0.3× 43 0.6× 14 518
Yu Hai China 10 243 1.6× 47 0.4× 110 0.9× 74 0.6× 76 1.1× 27 586
Giorgia Pierelli Italy 6 156 1.1× 145 1.1× 77 0.6× 86 0.8× 71 1.0× 7 494
Paul Modlinger United States 8 135 0.9× 211 1.7× 251 2.0× 91 0.8× 86 1.2× 9 653
Elyse Di Marco Australia 7 213 1.4× 103 0.8× 284 2.3× 39 0.3× 119 1.7× 9 782
Sohachi Fujimoto Japan 13 181 1.2× 163 1.3× 163 1.3× 207 1.8× 100 1.4× 18 747
Naoichi Sato Japan 7 203 1.4× 86 0.7× 198 1.6× 47 0.4× 114 1.6× 11 625
Nobuhiko Togashi Japan 13 173 1.2× 196 1.5× 222 1.8× 56 0.5× 165 2.3× 17 647

Countries citing papers authored by Verdiana Ravarotto

Since Specialization
Citations

This map shows the geographic impact of Verdiana Ravarotto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Verdiana Ravarotto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Verdiana Ravarotto more than expected).

Fields of papers citing papers by Verdiana Ravarotto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Verdiana Ravarotto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Verdiana Ravarotto. The network helps show where Verdiana Ravarotto may publish in the future.

Co-authorship network of co-authors of Verdiana Ravarotto

This figure shows the co-authorship network connecting the top 25 collaborators of Verdiana Ravarotto. A scholar is included among the top collaborators of Verdiana Ravarotto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Verdiana Ravarotto. Verdiana Ravarotto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ravarotto, Verdiana, et al.. (2023). Oxidants and Cardiorenal Vascular Remodeling—Insights from Rare Genetic Tubulopathies: Bartter’s and Gitelman’s Syndromes. Antioxidants. 12(4). 811–811. 1 indexed citations
2.
Ravarotto, Verdiana, et al.. (2022). Tracing angiotensin II's yin-yang effects on cardiovascular-renal pathophysiology. Minerva Medica. 114(1). 56–67. 3 indexed citations
3.
Ravarotto, Verdiana, et al.. (2022). Gitelman’s and Bartter’s Syndromes: From Genetics to the Molecular Basis of Hypertension and More. Kidney & Blood Pressure Research. 47(9). 556–564. 6 indexed citations
4.
Ravarotto, Verdiana, et al.. (2022). Pathomechanism of oxidative stress in cardiovascularrenal remodeling and therapeutic strategies. Kidney Research and Clinical Practice. 41(5). 533–544. 17 indexed citations
5.
Carraro, Gianni, et al.. (2022). The Effect of Green Tea as an Adjuvant to Enzyme Replacement Therapy on Oxidative Stress in Fabry Disease: A Pilot Study. Frontiers in Nutrition. 9. 924710–924710. 10 indexed citations
6.
Calò, Lorenzo A., et al.. (2021). ACE2 and SARS-CoV-2 Infection Risk: Insights From Patients With Two Rare Genetic Tubulopathies, Gitelman's and Bartter's Syndromes. Frontiers in Medicine. 8. 647319–647319. 6 indexed citations
7.
Ravarotto, Verdiana, et al.. (2021). The Pivotal Role of Oxidative Stress in the Pathophysiology of Cardiovascular-Renal Remodeling in Kidney Disease. Antioxidants. 10(7). 1041–1041. 27 indexed citations
8.
Francini‐Pesenti, Francesco, et al.. (2019). Could nutritional therapy take us further in our approaches to Fabry disease?. Nutrition. 72. 110664–110664. 11 indexed citations
9.
Ravarotto, Verdiana, et al.. (2018). Oxidative stress – chronic kidney disease – cardiovascular disease: A vicious circle. Life Sciences. 210. 125–131. 87 indexed citations
10.
Ravarotto, Verdiana, Johannes Loffing, Dominique Loffing‐Cueni, et al.. (2018). Gitelman’s Syndrome: characterization of a novel c.1181G>A point mutation and functional classification of the known mutations. Hypertension Research. 41(8). 578–588. 4 indexed citations
11.
Ravarotto, Verdiana, Gianni Carraro, Elisa Pagnin, et al.. (2018). Oxidative stress and the altered reaction to it in Fabry disease: A possible target for cardiovascular-renal remodeling?. PLoS ONE. 13(9). e0204618–e0204618. 26 indexed citations
12.
Ravarotto, Verdiana, Chiara Sabbadin, Elisa Pagnin, et al.. (2018). Proinflammatory/profibrotic effects of aldosterone in Gitelman’s syndrome, a human model opposite to hypertension. Journal of Endocrinological Investigation. 42(5). 521–526. 2 indexed citations
13.
Pagnin, Elisa, et al.. (2017). Gαq/p63RhoGEF interaction in RhoA/Rho kinase signaling: investigation in Gitelman’s syndrome and implications with hypertension. Journal of Endocrinological Investigation. 41(3). 351–356. 4 indexed citations
14.
Calò, Lorenzo A., Verdiana Ravarotto, Francesco Marchini, et al.. (2017). Pathophysiology of Post Transplant Hypertension in Kidney Transplant: Focus on Calcineurin Inhibitors Induced Oxidative Stress and Renal Sodium Retention and Implications with RhoA/Rho Kinase Pathway. Kidney & Blood Pressure Research. 42(4). 676–685. 13 indexed citations
15.
Seccia, Teresa Maria, Brasilina Caroccia, Maria Piazza, et al.. (2016). Endothelin‐1 Drives Epithelial‐Mesenchymal Transition in Hypertensive Nephroangiosclerosis. Journal of the American Heart Association. 5(7). 35 indexed citations
16.
Calò, Lorenzo A., Elisa Pagnin, Verdiana Ravarotto, et al.. (2016). Increased rho kinase activity in mononuclear cells of dialysis and stage 3–4 chronic kidney disease patients with left ventricular hypertrophy: Cardiovascular risk implications. Life Sciences. 148. 80–85. 29 indexed citations
17.
Calò, Lorenzo A., Paul A. Davis, Giuseppe Maiolino, et al.. (2015). Assessing the Relationship of Angiotensin II Type 1 Receptors with Erythropoietin in a Human Model of Endogenous Angiotensin II Type 1 Receptor Antagonism. Cardiorenal Medicine. 6(1). 16–24. 8 indexed citations
18.
Ravarotto, Verdiana, et al.. (2015). Angiotensin II and Cardiovascular-Renal Remodelling in Hypertension: Insights from a Human Model Opposite to Hypertension. High Blood Pressure & Cardiovascular Prevention. 22(3). 215–223. 8 indexed citations
19.
Calò, Lorenzo A., Paul A. Davis, Elisa Pagnin, et al.. (2013). Molecular biology based assessment of green tea effects on oxidative stress and cardiac remodelling in dialysis patients. Clinical Nutrition. 33(3). 437–442. 26 indexed citations
20.
Calò, Lorenzo A., Elisa Pagnin, Verdiana Ravarotto, et al.. (2013). Effect of olmesartan medoxomil on number and survival of circulating endothelial progenitor cells and calcitonin gene related peptide in hypertensive patients. Journal of Hypertension. 32(1). 193–199. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gema Marín‐Royo Breakdown of academic impact, for papers by Nicolas Godin Breakdown of academic impact, for papers by Jinjuan Fu Breakdown of academic impact, for papers by Yu Hai Breakdown of academic impact, for papers by Giorgia Pierelli Breakdown of academic impact, for papers by Paul Modlinger Breakdown of academic impact, for papers by Elyse Di Marco Breakdown of academic impact, for papers by Sohachi Fujimoto Breakdown of academic impact, for papers by Naoichi Sato Breakdown of academic impact, for papers by Nobuhiko Togashi
Rankless by CCL
2026